Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1

[1]  Brian J. From,et al.  Small , 2020, Definitions.

[2]  S. Hazen,et al.  Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo , 2016, eLife.

[3]  S. Reddy,et al.  Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux[S] , 2016, Journal of Lipid Research.

[4]  P. Chaudhuri,et al.  Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress. , 2015, Atherosclerosis.

[5]  C. Aguayo,et al.  Apolipoprotein A-I enhances proliferation of human endothelial progenitor cells and promotes angiogenesis through the cell surface ATP synthase. , 2015, Microvascular research.

[6]  C. Liang,et al.  Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathways. , 2015, Antioxidants & redox signaling.

[7]  J. Aronson.  Safety , 2009, BMJ : British Medical Journal.

[8]  C. White,et al.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review , 2014, Journal of Lipid Research.

[9]  S. Reddy,et al.  Apolipoprotein A-I mimetics , 2014, Current opinion in lipidology.

[10]  Bing Pan,et al.  Effects of diabetic HDL on endothelial cell function. , 2014, Cardiovascular & hematological disorders drug targets.

[11]  Salil Sharma,et al.  Apolipoprotein A-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p , 2014, Circulation.

[12]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[13]  P. Jiao,et al.  D-4F, an Apolipoprotein A-I Mimetic Peptide, Protects Human Umbilical Vein Endothelial Cells From Oxidized Low-Density Lipoprotein–induced Injury by Preventing the Downregulation of Pigment Epithelium-derived Factor Expression , 2014, Journal of cardiovascular pharmacology.

[14]  M. Reilly,et al.  Anti-inflammatory effects of high-density lipoprotein through activating transcription factor 3: benefit beyond cholesterol transport-dependent processes. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[15]  S. Hazen,et al.  Effects of Native and Myeloperoxidase-Modified Apolipoprotein A-I on Reverse Cholesterol Transport and Atherosclerosis in Mice , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[16]  K. Moore,et al.  High-density lipoproteins put out the fire. , 2014, Cell metabolism.

[17]  Bernd Hewing,et al.  High-Density Lipoprotein and Atherosclerosis Regression: Evidence From Preclinical and Clinical Studies , 2014, Circulation research.

[18]  S. Reddy,et al.  Searching for a successful HDL-based treatment strategy. , 2014, Biochimica et biophysica acta.

[19]  A. Nègre-Salvayre,et al.  Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids: Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[20]  Zhiping Wu,et al.  Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. , 2013, The Journal of clinical investigation.

[21]  Xiaoli Shen,et al.  High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair. , 2013, Free radical biology & medicine.

[22]  P. Jiao,et al.  Apolipoprotein A-I mimetic peptide reverse D-4F improves the biological functions of mouse bone marrow-derived late EPCs via PI3K/AKT/eNOS pathway , 2013, Molecular and Cellular Biochemistry.

[23]  G. Anantharamaiah,et al.  Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability. , 2013, Biochemical and biophysical research communications.

[24]  James R. Springstead,et al.  Abstract 11083: A Novel Approach to Oral ApoA-I Mimetic Therapy , 2012 .

[25]  Y. E. Chen,et al.  Diabetic HDL Is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression , 2012, PloS one.

[26]  A. Buck,et al.  Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F , 2012, Journal of Lipid Research.

[27]  J. Adamski,et al.  Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Shawn M. Gomez,et al.  Arp2/3 Is Critical for Lamellipodia and Response to Extracellular Matrix Cues but Is Dispensable for Chemotaxis , 2012, Cell.

[29]  S. Reddy,et al.  D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice[S] , 2012, Journal of Lipid Research.

[30]  Benjamin A. Hall,et al.  Transmembrane Helix Dynamics of Bacterial Chemoreceptors Supports a Piston Model of Signalling , 2011, PLoS Comput. Biol..

[31]  A. Akhmedov,et al.  Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. , 2011, The Journal of clinical investigation.

[32]  Feng Su,et al.  Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[33]  G. Getz,et al.  Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis , 2011, Journal of inflammation research.

[34]  S. Reddy,et al.  Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S] , 2011, Journal of Lipid Research.

[35]  K. Moore,et al.  HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells , 2011, Proceedings of the National Academy of Sciences.

[36]  Zhi-Guo Wang,et al.  Effects of isosorbide mononitrate on the restoration of injured artery in mice in vivo. , 2010, European journal of pharmacology.

[37]  A. Kontush,et al.  Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities , 2010, Current opinion in lipidology.

[38]  T. Lüscher,et al.  Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Prehypertension: Relation to Endothelial Dysfunction , 2010, Hypertension.

[39]  C. White,et al.  Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. , 2010, American journal of physiology. Cell physiology.

[40]  Costantina Manes,et al.  Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy , 2010, Circulation.

[41]  Xuelei S. Song,et al.  An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI , 2009, International journal of biological sciences.

[42]  S. Johnston,et al.  Statins , 2009, Neurology.

[43]  G. Nickenig,et al.  High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells , 2008, Journal of cellular and molecular medicine.

[44]  S. Reddy,et al.  Apolipoprotein A-I mimetic peptides , 2009, Current atherosclerosis reports.

[45]  S. Hazen,et al.  Apolipoprotein A-I Tryptophan Substitution Leads to Resistance to Myeloperoxidase-Mediated Loss of Function , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[46]  P. Goldschmidt-Clermont,et al.  ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: implications for vascular repair. , 2008, Biochimica et biophysica acta.

[47]  C. Mineo,et al.  The Scavenger Receptor Class B Type I Adaptor Protein PDZK1 Maintains Endothelial Monolayer Integrity , 2008, Circulation research.

[48]  B. De Geest,et al.  Human ApoA-I Transfer Attenuates Transplant Arteriosclerosis via Enhanced Incorporation of Bone marrow–derived Endothelial Progenitor Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[49]  D. Rader,et al.  patient-oriented and epidemiological research Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients , 2008 .

[50]  A. Tall,et al.  High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 , 2007, Proceedings of the National Academy of Sciences.

[51]  S. Reddy,et al.  Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Published, JLR Papers in Press, June 14, 2007. , 2007, Journal of Lipid Research.

[52]  W. Aronow,et al.  Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[53]  Paul Schoenhagen,et al.  Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. , 2007, JAMA.

[54]  D. Rader,et al.  High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I , 2005, Circulation research.

[55]  K. Pritchard,et al.  Effects of D-4F on Vasodilation and Vessel Wall Thickness in Hypercholesterolemic LDL Receptor–Null and LDL Receptor/Apolipoprotein A-I Double-Knockout Mice on Western Diet , 2005, Circulation research.

[56]  S. Reddy,et al.  An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[57]  K. Cunningham,et al.  The role of shear stress in the pathogenesis of atherosclerosis , 2005, Laboratory Investigation.

[58]  J. Voss,et al.  Tyrosine 192 in Apolipoprotein A-I Is the Major Site of Nitration and Chlorination by Myeloperoxidase, but Only Chlorination Markedly Impairs ABCA1-dependent Cholesterol Transport* , 2005, Journal of Biological Chemistry.

[59]  Michael Kinter,et al.  Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from Macrophages* , 2005, Journal of Biological Chemistry.

[60]  K. Miyazaki,et al.  Role of reactive oxygen species in inhibition of endothelial cell migration by oxidized low-density lipoprotein. , 2004, Journal of vascular surgery.

[61]  S. Hazen,et al.  The role of myeloperoxidase in the pathogenesis of coronary artery disease. , 2004, Japanese journal of infectious diseases.

[62]  John T. Fallon,et al.  High-Density Lipoproteins Retard the Progression of Atherosclerosis and Favorably Remodel Lesions Without Suppressing Indices of Inflammation or Oxidation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[63]  Michael Kinter,et al.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. , 2004, The Journal of clinical investigation.

[64]  S. Reddy,et al.  Oral D-4F Causes Formation of Pre-βHigh-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice , 2004, Circulation.

[65]  Akira Kawamura,et al.  High Density Lipoprotein–Induced Angiogenesis Requires the Activation of Ras/MAP Kinase in Human Coronary Artery Endothelial Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[66]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[67]  F. Ruschitzka,et al.  High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.

[68]  R. Lallone,et al.  Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol , 2002, Circulation.

[69]  R. Epand,et al.  Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. , 2001, Journal of lipid research.

[70]  A. Kettle,et al.  Myeloperoxidase , 2000, Current opinion in hematology.

[71]  D. Stafforini,et al.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. , 1995, The Journal of clinical investigation.

[72]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[73]  D. Janero,et al.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.

[74]  G. Anantharamaiah.  [36] Synthetic peptide analogs of apolipoproteins , 1986 .

[75]  G. Anantharamaiah.  Synthetic peptide analogs of apolipoproteins. , 1986, Methods in enzymology.

[76]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[77]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.